IL86603A - Hypoglycemic oxazolidin-2-one derivatives - Google Patents

Hypoglycemic oxazolidin-2-one derivatives

Info

Publication number
IL86603A
IL86603A IL86603A IL8660388A IL86603A IL 86603 A IL86603 A IL 86603A IL 86603 A IL86603 A IL 86603A IL 8660388 A IL8660388 A IL 8660388A IL 86603 A IL86603 A IL 86603A
Authority
IL
Israel
Prior art keywords
pharmaceutically
oxazolidin
salt
hypoglycemic
derivatives
Prior art date
Application number
IL86603A
Other languages
English (en)
Other versions
IL86603A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL86603A0 publication Critical patent/IL86603A0/xx
Publication of IL86603A publication Critical patent/IL86603A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL86603A 1987-06-10 1988-06-02 Hypoglycemic oxazolidin-2-one derivatives IL86603A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/001356 WO1988009661A1 (en) 1987-06-10 1987-06-10 Oxazolidin-2-one derivatives as hypoglycemic agents

Publications (2)

Publication Number Publication Date
IL86603A0 IL86603A0 (en) 1988-11-30
IL86603A true IL86603A (en) 1992-09-06

Family

ID=22202413

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86603A IL86603A (en) 1987-06-10 1988-06-02 Hypoglycemic oxazolidin-2-one derivatives

Country Status (21)

Country Link
US (1) US4968707A (de)
EP (1) EP0294995B1 (de)
JP (1) JPS649979A (de)
KR (1) KR900007313B1 (de)
AT (1) ATE82284T1 (de)
AU (1) AU585196B2 (de)
CA (1) CA1305152C (de)
DE (1) DE3875806T2 (de)
DK (1) DK313588A (de)
ES (1) ES2045116T3 (de)
FI (1) FI89479C (de)
GR (1) GR3007059T3 (de)
HU (1) HU203330B (de)
IE (1) IE62029B1 (de)
IL (1) IL86603A (de)
MY (1) MY103297A (de)
NO (1) NO171978C (de)
NZ (1) NZ224957A (de)
PT (1) PT87702B (de)
WO (1) WO1988009661A1 (de)
ZA (1) ZA884114B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02167224A (ja) * 1988-09-13 1990-06-27 Tanabe Seiyaku Co Ltd 抗脂血剤
US5356908A (en) * 1989-04-21 1994-10-18 E. I. Du Pont De Nemours And Company Fungicidal oxazolidinones
WO1991003474A1 (en) * 1989-08-29 1991-03-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
US5068342A (en) * 1989-10-27 1991-11-26 American Home Products Corporation 5-[(1- and 2-naphthalenyl)thio and sulfonyl]-2,4-thiazolidinediones and derivatives thereof
CA2083891A1 (en) * 1991-12-03 1993-06-04 Angus Murray Macleod Heterocyclic compounds, compositions containing them and their use in therapy
US5747501A (en) * 1992-04-07 1998-05-05 Pfizer, Inc. Indole derivatives
ES2139633T3 (es) * 1992-08-31 2000-02-16 Sankyo Co Derivados de oxazolidina con propiedades anti-diabetica y anti-obesidad, su preparacion y su utilizacion terapeutica.
AU668818B2 (en) * 1993-04-07 1996-05-16 Taiho Pharmaceutical Co., Ltd. Thiazolidine derivative and pharmaceutical composition containing the same
US5629200A (en) 1993-11-18 1997-05-13 Daicel Chemical Industries, Ltd. Production of optically active 2-amino-1-phenylethanol derivatives by asymetrical assimilation
IL113084A (en) * 1994-03-23 1999-01-26 Sankyo Co Thiazolidine and oxazolidine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
EP1465869B1 (de) 2001-12-21 2013-05-15 Exelixis Patent Company LLC Modulatoren von lxr
DOP2005000123A (es) * 2004-07-02 2011-07-15 Merck Sharp & Dohme Inhibidores de cetp
NZ556624A (en) * 2004-12-21 2010-06-25 Gilead Sciences Inc 5-((3-(2,4-trifluoromethyphenyl)isoxazol-5-yl)methyl)-2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridine and method of antiviral treatment
TW200732313A (en) * 2005-12-15 2007-09-01 Astrazeneca Ab Oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
NZ568904A (en) * 2005-12-30 2011-05-27 Merck Sharp & Dohme 1,3-oxazolidin-2-one derivatives useful as CETP inhibitors

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909467A (en) * 1958-07-09 1959-10-20 Us Vitamin Pharm Corp 3-(d-alpha-methylphenethyl)-5-methyl-1, 3-oxazolidine-2, 4-dione
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
DD153682A1 (de) * 1978-10-19 1982-01-27 Horst Bercher Verfahren zur herstellung neuer alkanolamine
DE3162756D1 (en) * 1980-05-22 1984-04-26 Beecham Group Plc Arylethanolamine derivatives, their preparation and use in pharmaceutical compositions
GB2080803B (en) * 1980-07-28 1984-01-18 Pfizer Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4407811A (en) * 1981-01-02 1983-10-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
ES515751A0 (es) * 1981-10-13 1983-10-16 Pfizer "un procedimiento por analogia para la preparacion de derivados de espiro-oxindol-oxazolidindiona".
GR78120B (de) * 1982-03-01 1984-09-26 Pfizer
JPS58183676A (ja) * 1982-04-19 1983-10-26 Takeda Chem Ind Ltd オキサゾ−ル誘導体
US4430337A (en) * 1982-06-23 1984-02-07 Pfizer Inc. Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity
US4617312A (en) * 1983-01-17 1986-10-14 Pfizer Inc. Aldose reductase inhibiting 5-(2-alkoxyphenyl) thiazolidinediones
EP0140359B1 (de) * 1983-11-02 1989-01-25 Beecham Group Plc Morpholin-Derivate
EP0142102B1 (de) * 1983-11-04 1987-09-23 Beecham Group Plc Tertiäre Amine
CA1249992A (en) * 1983-11-10 1989-02-14 Marcel Muller Oxazolidines
GB8412862D0 (en) * 1984-05-19 1984-06-27 Beecham Group Plc Compounds
GB8418657D0 (en) * 1984-07-21 1984-08-22 Beecham Group Plc Compounds
WO1986002073A1 (fr) * 1984-10-03 1986-04-10 Takeda Chemical Industries, Ltd. Derives de thiazolidinedione, procede de preparation et composition pharmaceutique les contenant
DE3438839A1 (de) * 1984-10-19 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische praeparate
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
US4738972A (en) * 1985-05-21 1988-04-19 Pfizer Inc. Hypoglycemic thiazolidinediones
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
US4873255A (en) * 1987-02-04 1989-10-10 Sankyo Company Limited Thiazolidinone derivatives, their preparation and their use
EP0295828A1 (de) * 1987-06-13 1988-12-21 Beecham Group Plc Chemische Verbindungen
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents

Also Published As

Publication number Publication date
KR900007313B1 (ko) 1990-10-08
HUT53623A (en) 1990-11-28
NO890529L (no) 1989-02-08
US4968707A (en) 1990-11-06
FI89479B (fi) 1993-06-30
ATE82284T1 (de) 1992-11-15
DE3875806D1 (de) 1992-12-17
PT87702B (pt) 1992-10-30
FI89479C (fi) 1993-10-11
WO1988009661A1 (en) 1988-12-15
NO171978B (no) 1993-02-15
IL86603A0 (en) 1988-11-30
AU585196B2 (en) 1989-06-08
NZ224957A (en) 1990-03-27
EP0294995A1 (de) 1988-12-14
JPH0448791B2 (de) 1992-08-07
PT87702A (pt) 1988-07-01
NO171978C (no) 1993-05-26
IE62029B1 (en) 1994-12-14
KR890000447A (ko) 1989-03-14
CA1305152C (en) 1992-07-14
HU203330B (en) 1991-07-29
DK313588A (da) 1989-02-10
ZA884114B (en) 1990-02-28
FI895815A0 (fi) 1989-12-05
DE3875806T2 (de) 1993-04-08
AU1753488A (en) 1988-12-15
GR3007059T3 (de) 1993-07-30
NO890529D0 (no) 1989-02-08
JPS649979A (en) 1989-01-13
DK313588D0 (da) 1988-06-09
EP0294995B1 (de) 1992-11-11
MY103297A (en) 1993-05-29
ES2045116T3 (es) 1994-01-16
IE881734L (en) 1988-12-10

Similar Documents

Publication Publication Date Title
IL86603A (en) Hypoglycemic oxazolidin-2-one derivatives
DE3668892D1 (en) Hypoglycemische thiazolidinedione.
HUT57044A (en) Process for producing phrmaceutical compositions having n-neuropeptide antagonistic effect and comprising imidazolyl alkylguanidine derivatives
AU672262B2 (en) Heterocyclically substituted phenyl-cyclohexane-carboxylic acid derivatives
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
MY102270A (en) New furanuronic acid derivatives, process their production and their use.
EP0270046A3 (en) Pharmaceutical composition for treatment of cataract
AU2443888A (en) Agents for treating high blood pressure and cardiac insufficiency
ZA939153B (en) Use of idazoxan and its derivatives for the preparation of a medicinal product intended for the treatment of parkinson's disease and its development
DK149492C (da) Analogifremgangsmaade til fremstilling af 3-alkylthio-2-acyloxypropyl-2'-trimethyl-ammonioethyl-phosphater
AU7117891A (en) Therapeutic agent for diabetic gangrene
RU94045839A (ru) Производные 3-(фенилалкиламиноалкилокси)-5-фенилпиразола, а также способ и промежуточные вещества для их получения, лекарственное средство, содержащее эти соединения
HUT45989A (en) Process for production of derivatives of 1,4-dihydropiridine and medical preparatives containing them as active substance
CA2216787A1 (en) 3-phenyl-1,4-dialkyl-1,2,4-triazolium salts and their use as antidepressants
MX9703359A (es) Acidos 2,2-dicloroalcancarboxilicos, proceso para su preparacion, medicamentos que los contienen y su uso para tratar resistencia a la insulina.

Legal Events

Date Code Title Description
RH Patent void